Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

CEPI: Driving Progress Toward Epidemic Preparedness and Response.

Identifieur interne : 000672 ( Main/Exploration ); précédent : 000671; suivant : 000673

CEPI: Driving Progress Toward Epidemic Preparedness and Response.

Auteurs : Dimitrios Gouglas ; Mario Christodoulou ; Stanley A. Plotkin ; Richard Hatchett

Source :

RBID : pubmed:31673694

Abstract

The Coalition for Epidemic Preparedness Innovations (CEPI) was formed in the aftermath of the 2014-2015 Ebola outbreak in west Africa to support the development of vaccines that could improve the world's preparedness against outbreaks of epidemic infectious diseases. Since its launch in 2017, CEPI has mobilized more than US$750 million to support its mission to develop vaccines against agents such as Lassa virus, Middle East respiratory syndrome coronavirus, and Nipah virus, as well as several rapid-response vaccine platforms to accelerate response times to unexpected epidemic threats. CEPI has also played a leading role in fostering institutional partnerships between public- and private-sector organizations to optimize allocation of resources for vaccine development against its priority pathogens. CEPI's priorities include diversification of its current vaccine research and development investment portfolio to include additional pathogens, such as Rift Valley fever and chikungunya; establishment of technical and regulatory pathways for vaccine development across CEPI's portfolio; development of sustainable manufacturing solutions for vaccine candidates nearing completion of safety and immunogenicity testing in humans; and creation of investigational stockpiles of its vaccine candidates for use in emergency situations. This commentary provides an overview of the global health challenges CEPI was established to address and its achievements to date, and indicates priorities for funding and coordination in the coming years.

DOI: 10.1093/epirev/mxz012
PubMed: 31673694


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">CEPI: Driving Progress Toward Epidemic Preparedness and Response.</title>
<author>
<name sortKey="Gouglas, Dimitrios" sort="Gouglas, Dimitrios" uniqKey="Gouglas D" first="Dimitrios" last="Gouglas">Dimitrios Gouglas</name>
</author>
<author>
<name sortKey="Christodoulou, Mario" sort="Christodoulou, Mario" uniqKey="Christodoulou M" first="Mario" last="Christodoulou">Mario Christodoulou</name>
</author>
<author>
<name sortKey="Plotkin, Stanley A" sort="Plotkin, Stanley A" uniqKey="Plotkin S" first="Stanley A" last="Plotkin">Stanley A. Plotkin</name>
</author>
<author>
<name sortKey="Hatchett, Richard" sort="Hatchett, Richard" uniqKey="Hatchett R" first="Richard" last="Hatchett">Richard Hatchett</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31673694</idno>
<idno type="pmid">31673694</idno>
<idno type="doi">10.1093/epirev/mxz012</idno>
<idno type="wicri:Area/PubMed/Corpus">000380</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000380</idno>
<idno type="wicri:Area/PubMed/Curation">000380</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000380</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000646</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000646</idno>
<idno type="wicri:Area/Ncbi/Merge">002383</idno>
<idno type="wicri:Area/Ncbi/Curation">002383</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002383</idno>
<idno type="wicri:Area/Main/Merge">000675</idno>
<idno type="wicri:Area/Main/Curation">000672</idno>
<idno type="wicri:Area/Main/Exploration">000672</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">CEPI: Driving Progress Toward Epidemic Preparedness and Response.</title>
<author>
<name sortKey="Gouglas, Dimitrios" sort="Gouglas, Dimitrios" uniqKey="Gouglas D" first="Dimitrios" last="Gouglas">Dimitrios Gouglas</name>
</author>
<author>
<name sortKey="Christodoulou, Mario" sort="Christodoulou, Mario" uniqKey="Christodoulou M" first="Mario" last="Christodoulou">Mario Christodoulou</name>
</author>
<author>
<name sortKey="Plotkin, Stanley A" sort="Plotkin, Stanley A" uniqKey="Plotkin S" first="Stanley A" last="Plotkin">Stanley A. Plotkin</name>
</author>
<author>
<name sortKey="Hatchett, Richard" sort="Hatchett, Richard" uniqKey="Hatchett R" first="Richard" last="Hatchett">Richard Hatchett</name>
</author>
</analytic>
<series>
<title level="j">Epidemiologic reviews</title>
<idno type="eISSN">1478-6729</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The Coalition for Epidemic Preparedness Innovations (CEPI) was formed in the aftermath of the 2014-2015 Ebola outbreak in west Africa to support the development of vaccines that could improve the world's preparedness against outbreaks of epidemic infectious diseases. Since its launch in 2017, CEPI has mobilized more than US$750 million to support its mission to develop vaccines against agents such as Lassa virus, Middle East respiratory syndrome coronavirus, and Nipah virus, as well as several rapid-response vaccine platforms to accelerate response times to unexpected epidemic threats. CEPI has also played a leading role in fostering institutional partnerships between public- and private-sector organizations to optimize allocation of resources for vaccine development against its priority pathogens. CEPI's priorities include diversification of its current vaccine research and development investment portfolio to include additional pathogens, such as Rift Valley fever and chikungunya; establishment of technical and regulatory pathways for vaccine development across CEPI's portfolio; development of sustainable manufacturing solutions for vaccine candidates nearing completion of safety and immunogenicity testing in humans; and creation of investigational stockpiles of its vaccine candidates for use in emergency situations. This commentary provides an overview of the global health challenges CEPI was established to address and its achievements to date, and indicates priorities for funding and coordination in the coming years.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Christodoulou, Mario" sort="Christodoulou, Mario" uniqKey="Christodoulou M" first="Mario" last="Christodoulou">Mario Christodoulou</name>
<name sortKey="Gouglas, Dimitrios" sort="Gouglas, Dimitrios" uniqKey="Gouglas D" first="Dimitrios" last="Gouglas">Dimitrios Gouglas</name>
<name sortKey="Hatchett, Richard" sort="Hatchett, Richard" uniqKey="Hatchett R" first="Richard" last="Hatchett">Richard Hatchett</name>
<name sortKey="Plotkin, Stanley A" sort="Plotkin, Stanley A" uniqKey="Plotkin S" first="Stanley A" last="Plotkin">Stanley A. Plotkin</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000672 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000672 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31673694
   |texte=   CEPI: Driving Progress Toward Epidemic Preparedness and Response.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31673694" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021